Recent studies have suggested that 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy'), a synthetic amphetamine derivative, might exhibit an anxiogenic-like activity in rodents. In this work, we examined the effects of MDMA (1, 8 and 15 mg kg −1 , i.p.) on social encounters between male mice using an ethopharmacological approach. Likewise, we compared the behavioural profile of MDMA with that induced by FG 7142 (15 mg kg −1 , i.p.), an anxiogenic benzodiazepine receptor ligand. Individually housed mice were exposed to anosmic standard opponents 30 min after drug administration, and the encounters were videotaped and evaluated using an ethologically based analysis. MDMA (8 and 15 mg kg −1 ) produced a behavioural pattern characterized by a marked decrease of aggression (threat and attack) as well as social investigation, body care and digging behaviours, without affecting immobility. Moreover, avoidance/flee and defence/submission behaviours were significantly increased by the drug. A very similar behavioural profile was observed in FG 7142-treated animals. Overall, these findings might indicate that MDMA has anxiogenic-like properties in male mice.
INTRODUCTION
3,4-methylenedioxymethamphetamine (MDMA) is a bicyclic amphetamine derivative popularly known as 'ecstasy'. Despite the legislative restriction of its use, MDMA is consumed as a recreational substance because of its ability to induce a novel state of consciousness comprised of altered mood and enhanced perception of emotions, being readily available as an illicit drug at many clubs and recreational venues [1] [2] [3] .
MDMA mainly acts as a releaser of serotonin (5-HT) and, to a lesser extent, of dopamine (DA) [4] . This release of dopamine is probably due to a direct interaction of MDMA with the DA-carrier, although there is also evidence that the concomitant MDMA-induced release of 5-HT amplifies DA release through activation of postsynaptic 5-HT2 receptors [5, 6] . It has highest affinity for the 5-HT uptake site (<1 µM) with lower but comparable affinities at 5-HT2, alpha-2 adrenergic, M1 cholinergic and H1 histamine receptors (K i values < 6 µM) [7] .
The risk of adverse reactions to 'ecstasy' is widely known. As the popularity of 'ecstasy' has increased, psychiatric problems associated with its repeated use have emerged, with induction of anxiety, panic attacks and paranoia being the most frequently described complications [8, 9] . Available evidence for acute anxiogenic effects of the drug from human studies using 'pure' MDMA is controversial. Some authors reported anxiolytic effects of MDMA as assessed by the State-Trait Anxiety Inventory under placebo-controlled conditions [10] or retrospectively [11] . Other studies using different psychometric measures found increments in anxiety after MDMA or methylenedioxyamphetamine (MDE) consumption [12, 13] .
On the other hand, numerous studies have provided extensive evidence for the neurotoxic effects of MDMA in rodents and monkeys [14] [15] [16] . Its possible neurotoxicity in humans led to the assignment of MDMA as a Schedule I compound by the US Drug Enforcement Agency in 1985.
We have recently reported that MDMA (5-20 mg kg −1 ) exhibited in mice a behavioural profile characterized by a reduction of aggression, accompanied by a decrease of social investigation and an increase of exploration from a distance, avoidance/flee and defence/submission behaviours [17] . This ethopharmacological pattern could indicate the existence of an anxiogenic-like effect of the drug. However, Lin et al. [18] have recently reported that MDMA induced not only anxiogenic-like properties at a 4 mg kg −1 dose but also anxiolytic effects at a dose of 20 mg kg −1 in the elevated plus maze test. The aim of the present study was to examine this possible anxiogenic-like activity of MDMA (1, 8 and 15 mg kg −1 ) in social encounters between male mice, using an isolation-induced aggression model. Likewise, we compared the effects of MDMA with those induced by FG 7142 (15 mg kg −1 ), a benzodiazepine receptor ligand which has been demonstrated to possess clear anxiogenic properties in various animal models [19, 20] .
MATERIALS AND METHODS

Animals
Albino male mice of the OF.1 strain (n = 120) weighing 25-30 g were used (CRIFFA, Barcelona, Spain). Animals were housed under standardized lighting conditions (white lights on: 20:00-08:00) at a constant temperature (21 • C) and food and tap water were available ad libitum, except during behavioural trials. Upon arrival in the laboratory, the subjects were allocated to two different categories. Half were housed individually in transparent plastic cages (24 × 13.5 × 13 cm) as experimental animals. The remainder were housed in groups of five to be used as 'standard opponents' and were rendered temporally anosmic by intranasal lavage with 4% zinc sulphate solution (Sigma Laboratories, Madrid, Spain) administered 1 and 3 days before testing. Fighting in mice, as in most rodents, is closely related to olfaction. We used this type of opponent because it elicits attack but never initiates such behaviour [21] . These animals very rarely direct spontaneous attacks towards the test animals and, consequently, fighting is always unidirectional, being easily quantified.
All the experimental animals underwent an isolation period of 30 days before the behavioural test (isolationinduced aggression model). Social isolation is an effective form of increasing the level of aggressiveness in different species of animals. This phenomenon is particularly well demonstrated in laboratory mice [22, 23] .
This experiment was carried out in accordance with the guiding principles for care and use of laboratory animals approved by the European Communities Council Directive of November 24, 1986 (86//609/EEC).
Drug treatment
MDMA (Sigma Laboratories, Madrid, Spain) was diluted in physiological saline to provide appropriate doses for injections. It was administered acutely in three doses: 1, 8 and 15 mg kg −1 . FG 7142 was diluted in DMSO (0.5 ml) plus two drops of Tween-80. The control group received physiological saline. Drugs and vehicle were injected intraperitoneally in a volume of 0.1 ml g −1 body weight. All doses were selected on the basis of a pilot study carried out previously in our laboratory.
Agonistic encounters and behavioural analysis
Thirty minutes after injection, an isolated animal and a 'standard opponent' (marked with fur dye for identification) were allowed to confront each other in a neutral area for 10 min. This neutral cage consisted of an all glass area, measuring 50 × 26 × 30 cm with a fresh sawdust substrate. Before the encounter, the animals were allowed 1 min of adaptation to the neutral cage, remaining separated by means of a plastic barrier throughout this time. The social encounters were videotaped using a Sony-V8 camera. All tests were conducted under red light between the second and seventh hours of the dark phase of the artificial cycle of the animals. After each encounter, the neutral cage was washed out and the sawdust bedding was replaced. The tapes were analysed using a microprocessor and a custom-developed programme [24] , which facilitated estimation of time allocated to ten broad behavioural categories. The names of the categories and their constituent elements are as follows: (i) body care (which includes groom, self-groom, wash, shake, scratch); (ii) digging (dig, kick dig, push dig); (iii) nonsocial exploration (explore, rear, supported rear, scan); (iv) exploration from a distance (approach, attend, circle, head orient, stretched attention); (v) social investigation (crawl over, crawl under, follow, groom, head groom, investigate, nose sniff, sniff, push past, walk around); (vi) threat (aggressive groom, sideways offensive, upright offensive, tail rattle); (vii) attack (charge, lunge, attack, chase); (viii) avoidance/flee (evade, flinch, retreat, ricochet, wheel, startle, jump, leave, wall, clutch); (ix) defence/submission (upright defensive, upright submissive, sideways defensive); (x) immobility (squat, cringe).
A detailed description of all the above-mentioned elements can be found in Brain et al. [24] . This ethoexperimental procedure allows a complete quantification of the behavioural elements shown by the subject during the agonistic encounters. Only the behaviour of the isolated animal was assessed. The analysis was carried out by a trained experimenter who was unaware of the treatment administered to the groups.
Statistical analysis
The medians for times allocated to each behavioural category were determined. Non-parametric KruskalWallis tests were used to assess the variance of the behavioural measures over different treatment groups. Subsequently, appropriate paired comparisons were carried out using Mann-Whitney U -tests to contrast the behaviour in the different treatment groups. The analysis was performed using non-parametric statistics since the criteria for the parametric statistics were not met by the data. A value of P< 0.05 was considered to be statistically significant. On the other hand, mice treated with FG 7142 showed a significant reduction in the behavioural categories of digging (P< 0.001) and social investigation (P< 0.05), whereas exploration from a distance (P< 0.01) and defence/submission (P< 0.05) behaviours were significantly increased after treatment with the drug, in comparison with the control group. Although FG 7142 also reduced body care, threat and attack behaviours, no statistically significant differences were reached. The median values for the behavioural category of immobility were zero for all groups.
RESULTS
Paired comparisons based on significant
DISCUSSION
As Table I indicates, MDMA (8 and 15 mg kg −1 ) provoked a marked decrease of offensive behaviours (threat and attack) in isolated male mice, without a concomitant increase of immobility. However, other behavioural categories were clearly affected, suggesting that the anti-aggressive action of MDMA was unselective. Thus, avoidance/flee and defence/submission behaviours were significantly enhanced after treatment with the drug. Furthermore, the composite of reduced social investigation/enhanced exploration from a distance is consistent with an increase in anxiety. In addition, the increase of time spent in non-social exploration behaviours may reflect attempts to escape from the test arena. Therefore, overall, this ethopharmacological profile might indicate the existence of an anxiogenic-like activity of MDMA in mice. In fact, such behavioural categories have been frequently used to assess the anxiety-changing properties of drugs [25, 26] .
The behavioural changes observed in our experiment cannot be simply explained by drug-induced compulsive hyperlocomotion. Although we have not included in our behavioural analysis a specific measure of distance travelled by the animal, some parameters evaluated in our paradigm give information relevant in relation to the level of motor activity shown by the mice. In this sense, it has been reported that a substance with a clear hyperlocomotor effect, such as amphetamine, provokes a significant increase in the behavioural category of non-social exploration [27] . In our study, similar changes in this parameter were observed. Nevertheless, we do no consider that the behavioural changes exhibited by the animals can be interpreted as drug-induced hyperlocomotion. Thus, the marked increases in the behavioural categories of avoidance/flee and defence/submission, which have been traditionally related to an 'anxiogenic-like' profile [25] , are not affected by a possible MDMA-induced hyperlocomotion at high doses. Additionally, the behaviours of defence (which were clearly augmented by the drug) are not compatible with a state of hyperlocomotion. Thus, in this behavioural category are considered postures such as upright defence (bipedal postures, usually oriented towards the partner accompanied by widening of the eyes and raising of the ears), upright submission (an extreme form of 'upright defence' with the head pushed far backwards and with the forelimbs held rigid and widely splayed), and sideways defence (tripedal postural, one forepaw raised from the ground, accompanied by widening of the eyes and raising of the ears). These behaviours are maintained until the opponent goes away.
This behavioural profile of MDMA was similar to that observed after administration of FG 7142 (15 mg kg −1 ), a known substance with anxiogenic activity. In fact, as can be seen in Table I , after acute treatment with this compound mice showed a significant increase of defence/submission and exploration from a distance behaviours, accompanied by a marked reduction of digging and social investigation behaviours. The anxiogenic effect of FG 7142, a drug which acts as a partial inverse agonist at benzodiazepine receptors, has been repeatedly demonstrated in several animal models of anxiety [19, 20] .
In line with our previous findings [17] , MDMA (5-20 mg kg −1 , i.p.) exhibited an anxiogenic-like profile in agonistic encounters between male mice. Likewise, the results of the present experiment are in concordance with recent studies in which an anxiogenic-like action has been described using animal models of anxiety such as the elevated plus-maze [18, 28] and the light/dark box tests [29] . Nevertheless, in a recent study [30] , it was found that MDMA had both anxiogenic and anxiolytic effects depending upon the test situation employed. Specifically, MDMA had anxiolytic properties in rats exposed to emergence, elevated plus-maze and cat odour avoidance tests, while causing anxiolytic effects in the social interaction and footshock-induced ultrasonic vocalization tests. This bimodal behavioural profile in animals with prosocial and anti-aggressive effects on one side and clear anxiogenic properties on the other is also in line with the drug's effects in humans, where both anxiogenic and anxiolytic effects have been described [10] [11] [12] [13] .
The precise mechanism by which MDMA could provoke this effect on anxiety remains unknown; however, the massive and prolonged stimulation of 5-HT release and the increased dopaminergic activity might be responsible for the anxiogenic-like effects of MDMA, especially at high doses. In fact, there is growing evidence suggesting that the serotonergic and dopaminergic systems are involved in the modulation of anxiety [31] [32] [33] . 
